Trending Now
Dare Biosciences Inc. (NASDAQ:DARE) Reports Positive DARE-BV1 Study Results In Bacterial...
Dare Biosciences Inc. (NASDAQ:DARE) has announced encouraging top-line DARE-BVFREE Third Phase double-blinded, randomized, placebo-controlled clinical study results. The study evaluated the company's DARE-BV1 in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...
CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...
MAKE IT MODERN
LATEST REVIEWS
C3.ai Inc (NYSE:AI) gains over 30% in 3 days on strength...
ChatGPT has taken the world by storm and Buzzfeed (BZFD) got the party started with a ChatGPT PR last week which sent...
MAKE IT MODERN
PERFORMANCE TRAINING
BioNTech SE (NASDAQ:BNTX) And Pfizer Inc. (NYSE:PFE) Sign Agreement To Supply COVID-19 Vaccine To...
Germany-based BioNTech SE (NASDAQ:BNTX) and its partner Pfizer Inc. (NYSE:PFE) entered an agreement with Costa Rica for the manufacture and supply of up to...
Invesco QQQ Trust (QQQ) is on the recovery rally mode
Invesco QQQ Trust (QQQ) last traded at $280.97+1.92 (+0.69%). QQQ traded in the range of $276.17 - $281.21 with more than 44,802,936 shares...
The Health Food Space Keeps Roaring (MED, SBEV, WW)
The functional foods market saw sales top $267 billion in February of this year on a global basis, with sales in the US reaching...
BioMarin Pharmaceuticals Inc. (NASDAQ:BMRN) Reports Net Revenue Of $460.7 Million In Q3 2020
BioMarin Pharmaceuticals Inc. (NASDAQ:BMRN) has announced its Q3 financial results for the quarter ended September 30, 2020, in which net product revenue was $460.7...
Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) Report Encouraging FDA Meeting Results For MAT9001 in SHTG
Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) has announced the End of Phase two meeting with the FDA regarding the registration pathway and development for MAT9001,...
MAKE IT MODERN
